Cardiac Rhythm Management (CRM) Devices - Global Trends, Estimates and Forecasts, 2012-2018

News provided by

Dec 19, 2014, 11:18 ET

DUBLIN, Dec. 19, 2014 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/m2frqn/cardiac_rhythm) has announced the addition of the "Cardiac Rhythm Management (CRM) Devices - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Supported by the largest segment types Cardiac Defibrillators, global Cardiac Rhythm Management Devices market value is projected to reach US$20.9 billion by 2017, with a CAGR of 10% during 2012-2018.

Global Market Watch:

The Cardiac Rhythm Management Devices market value is expected to reach US$20.9 billion by 2017, primarily supported by the product types - Cardiac Defibrillators, Cardiac Pacemakers Devices and Cardiac Resynchronization Therapy. Globally, Cardiac Defibrillators and Pacemakers Devices together account for approximately 80% of the market share to support the Cardiac Rhythm Management Devices Industry going forward.

Geographical analysis for Cardiac Defibrillators market shows that the highest Compounded Annual Growth Rate (CAGR) of 11% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Europe follows Asia-Pacific with a CAGR of 8.7% while the North America forecasts to drive with a growth rate of 8.2%.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report Cardiac Rhythm Management (CRM) Devices - Global Trends, Estimates and Forecasts, 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

Companies Mentioned: